Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients

Br J Haematol. 2020 Dec;191(5):e120-e124. doi: 10.1111/bjh.17084. Epub 2020 Sep 18.
No abstract available

Keywords: blast phase MPN; decitabine; venetoclax; zacitidine.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Blast Crisis* / drug therapy
  • Blast Crisis* / mortality
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Disease-Free Survival
  • Female
  • Hematologic Neoplasms* / drug therapy
  • Hematologic Neoplasms* / mortality
  • Humans
  • Male
  • Middle Aged
  • Myeloproliferative Disorders* / drug therapy
  • Myeloproliferative Disorders* / mortality
  • Retrospective Studies
  • Sulfonamides / administration & dosage
  • Survival Rate

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • venetoclax